The FDA approved a Genentech multiple-sclerosis drug called Ocrevus, the first treatment for the most severe type of MS.
WSJ.com: Health, Wall Street Journal: Business: Health
Tue, 03/28/2017 - 8:08pm
The FDA approved a Genentech multiple-sclerosis drug called Ocrevus, the first treatment for the most severe type of MS.